Back
Nu Skin Enterprises 10K Form
Sell
49
NUS
Nu Skin Enterprises
Last Price:
7.68
Seasonality Move:
-0.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | NUS/Nu Skin Enterprises Quarterly |
2023-11-02 | 10Q | NUS/Nu Skin Enterprises Quarterly |
2023-08-02 | 10Q | NUS/Nu Skin Enterprises Quarterly |
2023-05-04 | 10Q | NUS/Nu Skin Enterprises Quarterly |
2022-11-03 | 10Q | NUS/Nu Skin Enterprises Quarterly |
2022-08-05 | 10Q | NUS/Nu Skin Enterprises Quarterly |
Receive NUS News And Ratings
See the #1 stock for the next 7 days that we like better than NUS
NUS Financial Statistics
Sales & Book Value
Annual Sales: | $1.97B |
---|---|
Cash Flow: | $22.84M |
Price / Cash Flow: | 4.07 |
Annual Sales: | $14.22 |
Price / Book: | 0.52 |
Profitability
EPS (TTM): | -2.07000 |
---|---|
Net Income (TTM): | $-103.21M |
Gross Margin: | $1.36B |
Return on Equity: | -13.41% |
Return on Assets: | -6.06% |
Nu Skin Enterprises Earnings Forecast
Key Nu Skin Enterprises Financial Ratios
- The Gross Profit Margin over the past 29 years for NUS is 68.93%.
- The Selling, General & Administrative Expenses for NUS have been equal to 65.47% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of NUS is 0.44% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 15 years.
Nu Skin Enterprises Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Personal Care Products |
Sector: | Consumer Staples |
Current Symbol: | NUS |
CUSIP: | 67018T |
Website: | nuskin.com |
Debt
Debt-to-Equity Ratio: | 0.61 |
---|---|
Current Ratio: | 1.93 |
Quick Ratio: | 0.9 |
Price-to-Earnings
Trailing P/E Ratio: | 43.76 |
---|---|
Forward P/E Ratio: | 7.53 |
NUS Technical Analysis vs Fundamental Analysis
Sell
49
Nu Skin Enterprises (NUS)
is a Sell
Is Nu Skin Enterprises a Buy or a Sell?
-
Nu Skin Enterprises stock is rated a Sell
The current Nu Skin Enterprises [NUS] share price is $7.44. The Score for NUS is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.